Industry News
E-Prescribing Mandate in Illinois: What You Need to Know
Starting January 1, 2024, Illinois will require all healthcare providers who prescribe controlled substances to submit prescriptions electronically. This new legislation, known as the E-Prescribing Mandate, aims to enhance patient safety, reduce prescription errors, and combat prescription drug abuse by ensuring more secure and accurate prescribing practices.
Novo Nordisk’s Sudden Discontinuation of Essential Insulin Brand
In a recent move that sparked significant concern, Novo Nordisk, a major pharmaceutical company, announced the discontinuation of Levemir, a widely used long-acting insulin, prompting urgent inquiries from U.S. Senators. Senators Jeanne Shaheen (D-NH), Raphael Warnock (D-GA), and Elizabeth Warren (D-MA) have voiced their alarm and are demanding explanations from the company, citing concerns over patient access to affordable insulin alternatives.
